Well after a year on ADT as part of a clinical trial at a major center of excellence, I met online with the RO today for a follow up (I had 37 treatments of IMRT in February). Previous to that I had RP in June 19, pathology showed Gleason 4+3, ECE, seminal vesicle invasion and 1 of 12 lymph nodes positive. Not great, so I signed up for the recommended trial. Aggressive, with Lupron, Taxotere and Zytiga starting at 3 months post op followed by the radiation. PSA has been undetectable throughout but I know I'm definitely high risk.
The ADT was scheduled for 2 years.
HOWEVER, when I met with the RO today, he asked how I was doing and I told him (that's what he gets for asking), especially about how much ADT sucks (in detail), as if he didn't know. I've been tolerating it well but of course it's swimming upstream of course. So he says, 'well I think you can quit that now'. He also said I should contact my MO who's running the trial and tell him what I'd just said. So I did. And the MO says THE SAME THING to me.... 'You can stop now at a year, the benefits of staying on it longer are unclear'.
This is sort of great news-don't get me wrong, I'm damn glad I said something-but it feels weird. Like if I hadn't bitched about it a little I would just be on Lupron for the full 2 crappy years. No mention was ever made previously of cutting it short.
(I know full well I may be prescribed it again if I have a recurrence, but I can't help to be glad to let the T rise and see what happens sooner than later)
My question is simple: Is there really this little proven efficacy for courses of ADT longer than a year in high risk patients? The doctors both seemed pretty nonchalant about letting me stop early.